The effects of Zoledronate on human peripheral blood mononuclear cells
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
Zoledronate is well known to act on osteoclasts to inhibit bone resorption.Zoledronate is administrated intravenously in clinical use, however, actions of zoledronate on cells in blood circulation are not fully understood. To understand its actions of human peripheral blood mononuclear cells (h-PBMC), we performed gene expression profiling in zoledronate-treated h-PBMC. h-PBMC were incuvated for 8 hours with 5 mM of Zoledronate (Zol. (+)) or without (Zol. (-)).
创建时间：
2019-10-12
